Ledger.Open graph →
SEC Form D · Amendment · filed April 29, 2016

Merganser Biotech, Inc

Offering
$17.1M
Sold
$13.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
King of Prussia, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James Topper · Seattle, WADirectorColin Goddard · West Conshohocken, PADirectorMarkus Goebel · Sunnyvale, CADirectorBrian Macdonald · San Francisco, CAExec · DirectorRemy Sukhija · King of Prussia, PAExecJeffrey Bird · Palo Alto, CADirectorJames Topper · Newton, MADirectorColin Goddard · Newtown Square, PADirectorMarkus Goebel · King of Prussia, PADirectorBrian Macdonald · Newtown Square, PAExec · DirectorRemy Sukhija · King of Prussia, PAExecJeffrey Bird · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗